text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 29110-48-3 | Product Number: G0414

Guanfacine Hydrochloride

Purity: >98.0%(T)(HPLC)
  • N-(Aminoiminomethyl)-2,6-dichlorobenzeneacetamide Hydrochloride
  • N-Amidino-2-(2,6-dichlorophenyl)acetamide Hydrochloride
1   Contact Us
10   1  

* Please contact our distributors or TCI to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.

Product Number G0414
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__9H__9Cl__2N__3O·HCl = 282.55  
Physical State (20 deg.C) Solid
Packaging and Container 100MG-Glass Bottle with Plastic Insert (View image)
CAS RN 29110-48-3
Related CAS RN 29110-47-2
Reaxys Registry Number 6019938
PubChem Substance ID 253662104
Merck Index (14) 4561
MDL Number


Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 211.0 to 215.0 °C
Properties (reference)
Melting Point 213 °C
Pictogram Pictogram
Signal Word Danger
Hazard Statements H301 : Toxic if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
P405 : Store locked up.
Related Laws:
RTECS# CY1481000
Transport Information:
UN Number UN2811
Class 6.1
Packing Group III
H.S.code* 2925.29-000
*This code is applied to the products when TCI exports from Japan and not for import in your country.
Guanfacine Hydrochloride: A Centrally Acting α2A-Adrenoceptor Agonist

Guanfacine hydrochloride, a phenylacetyl-guanidine derivative, is a centrally acting α2A-adrenoceptor agonist with a mechanism of antihypertensive action similar to that of clonidine [D1353]. It reduces blood pressure in human with essential hypertension (EH) at least as effectively as clonidine or methyldopa [D1817]. Recent research has found that guanfacine can improve prefrontal cortex (PFC) function by strengthening PFC network connections via inhibition of cAMP-potassium channel signaling in postsynaptic spines. Guanfacine is now being used to treat a variety of PFC cognitive disorders, including attention deficit/hyperactivity disorder (ADHD). (The product is for research purpose only.)


PubMed Literature

Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents